Filing Details

Accession Number:
0001842952-23-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-30 16:03:31
Reporting Period:
2023-01-30
Accepted Time:
2023-01-30 16:03:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1842952 Context Therapeutics Inc. CNTX Pharmaceutical Preparations (2834) 863738787
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1861989 A. Martin Lehr 2001 Market Street
Suite 3915, Unit #15
Philadelphia PA 19103
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-30 7,027 $0.70 143,232 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 820,190 Indirect Martin Lehr 2000 Trust
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022.
  2. The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.682 - $0.70. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.